Literature DB >> 854242

Endometrial stromatosis of the uterus.

W R Hart, M Yoonessi.   

Abstract

This study details the clinicopathologic features of 9 patients with endometrial stromatosis of the uterus, including 1 with the circumscribed variant. The potential of stromatosis for local invasion, intravascular penetration, and pulmonary metastasis is documented. Recurrent lesions often develop late, are amenable to surgical therapy, and do not necessarily portend a fatal outcome. Our findings and those of others indicate that the histopathologic appearance and relatively indolent behavior of stromatosis are sufficiently characteristic to justify its separation from the more aggressive homologous endometrial stromal sarcomas.

Entities:  

Mesh:

Year:  1977        PMID: 854242

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  4 in total

1.  Metastatic low-grade endometrial stromal sarcoma of the sigmoid colon three years after hysterectomy.

Authors:  Yuki Asada; Hajime Isomoto; Fumitaka Akama; Noriko Nomura; Chun-Yang Wen; Haruhiko Nakao; Ikuo Murata; Kan Toriyama; Shigeru Kohno
Journal:  World J Gastroenterol       Date:  2005-04-21       Impact factor: 5.742

2.  Long-term survival of patients given hormonal therapy for metastatic endometrial stromal sarcoma.

Authors:  J-P Spano; J-C Soria; M Kambouchner; S Piperno-Neuman; F Morin; J-F Morere; A Martin; J-L Breau
Journal:  Med Oncol       Date:  2003       Impact factor: 3.064

Review 3.  Endometrial stromal tumours of the uterus: a practical approach using conventional morphology and ancillary techniques.

Authors:  Patricia Baker; Esther Oliva
Journal:  J Clin Pathol       Date:  2007-03       Impact factor: 3.411

4.  Clinical study investigating the role of lymphadenectomy, surgical castration and adjuvant hormonal treatment in endometrial stromal sarcoma.

Authors:  F Amant; A De Knijf; B Van Calster; K Leunen; P Neven; P Berteloot; I Vergote; S Van Huffel; P Moerman
Journal:  Br J Cancer       Date:  2007-09-25       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.